From the *Unit of Nuclear Medicine, Department of Diagnostic Services, San Paolo Hospital; †Department of Health Sciences, and ‡Centre for Research and Treatment of Cognitive Dysfunctions, Institute of Clinical Neurology, Department of Biomedical and Clinical Sciences "Luigi Sacco" Hospital, University of Milan, Milan, Italy.
Clin Nucl Med. 2015 Jan;40(1):32-5. doi: 10.1097/RLU.0000000000000602.
Although parkinsonism is considered a core feature of dementia with Lewy bodies (DLB), it is occasionally mild or even absent. I-FP-CIT SPECT has been accepted as a diagnostic support tool in this context, given that low striatal uptake is associated with neuronal loss. The aim of this retrospective study was to look for correlations between I-FP-CIT uptake in the striatum and clinical extrapyramidal signs (EPSs) in patients with a diagnosis of probable DLB to clarify the extent to which the supporting role of I-FP-CIT is related to motor impairment.
Semiquantitative I-FP-CIT uptake was analyzed and correlated with Unified Parkinson Disease Rating Scale Part III scores in a sample of 22 patients with a diagnosis of probable DLB and a wide range of EPSs.
A significant negative linear correlation between I-FP-CIT uptake and Unified Parkinson Disease Rating Scale Part III score was found both in the caudate and the putamen (r = -0.69 and -0.72, respectively, P < 0.001). Striatal uptake in patients with no or questionable EPS was comparable to that recorded in normal age-matched subjects (99% [22%] in the putamen) but significantly reduced in those with mild and severe EPS (43% [35%] and 30% [17%], respectively, P < 0.0001, but P = nonsignificant between mild and severe EPS).
SPECT may be redundant when there are no doubts about the parkinsonism (ie, when it is absent or unequivocally present), but it may be helpful in identifying presynaptic nigrostriatal degeneration in patients with mild EPSs.
虽然帕金森病被认为是路易体痴呆(DLB)的核心特征,但它偶尔也会表现为轻度或甚至不存在。在这种情况下,I-FP-CIT SPECT 已被接受为一种诊断支持工具,因为纹状体摄取量低与神经元丢失有关。本回顾性研究的目的是寻找诊断为可能的 DLB 的患者纹状体中 I-FP-CIT 摄取与临床锥体外系体征(EPS)之间的相关性,以阐明 I-FP-CIT 的支持作用与运动障碍的相关性程度。
对 22 名诊断为可能的 DLB 且 EPS 范围广泛的患者进行半定量 I-FP-CIT 摄取分析,并与统一帕金森病评定量表第三部分评分相关。
在尾状核和壳核中均发现 I-FP-CIT 摄取与统一帕金森病评定量表第三部分评分之间存在显著的负线性相关性(r = -0.69 和 -0.72,分别为 P < 0.001)。无或可疑 EPS 的患者的纹状体摄取与年龄匹配的正常受试者相似(壳核为 99% [22%]),但在轻度和重度 EPS 的患者中显著降低(分别为 43% [35%]和 30% [17%],P < 0.0001,但轻度和重度 EPS 之间无显著差异,P = 无意义)。
当不存在帕金森病(即缺失或明确存在)时,SPECT 可能是多余的,但在轻度 EPS 患者中,它可能有助于识别突触前黑质纹状体变性。